Literature DB >> 27198137

Renal involvement in primary antiphospholipid syndrome.

Carmelita Marcantoni1, Carmela Emmanuele2, Francesco Scolari3.   

Abstract

Antiphospholipid syndrome is an autoimmune disorder characterized by recurrent venous or arterial thrombosis and/or pregnancy-related problems associated with persistently elevated levels of antiphospholipid antibodies. The kidney is a major target organ in both primary and secondary antiphospholipid syndrome. This review describes several aspects of the renal involvement in the primary form of the syndrome, in particular the histological pattern of the so-called antiphospholipid syndrome nephropathy (APSN). APSN is a vascular nephropathy characterized by small vessel vaso-occlusive lesions associated with fibrous intimal hyperplasia of interlobular arteries, recanalizing thrombi in arteries and arterioles, and focal atrophy, a constellation of morphological lesions suggestive of primary antiphospholipid syndrome.

Entities:  

Keywords:  Anti-β2GPI antibodies; Antiphospholipid antibodies; Pregnancy loss; Thrombotic microangiopathy

Mesh:

Year:  2016        PMID: 27198137     DOI: 10.1007/s40620-016-0317-2

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  56 in total

Review 1.  Correct laboratory approach to APS diagnosis and monitoring.

Authors:  V Pengo; A Banzato; G Denas; S Padayattil Jose; E Bison; A Hoxha; A Ruffatti
Journal:  Autoimmun Rev       Date:  2012-12-03       Impact factor: 9.754

2.  IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.

Authors:  Taraneh Mehrani; Michelle Petri
Journal:  J Rheumatol       Date:  2010-12-01       Impact factor: 4.666

3.  A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Authors:  G Finazzi; R Marchioli; V Brancaccio; P Schinco; F Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; T Barbui
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

4.  Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis.

Authors:  G S Friedman; H U Meier-Kriesche; B Kaplan; A S Mathis; L Bonomini; N Shah; P DeFranco; M Jacobs; S Mulgaonkar; S Geffner; N Lyman; C Paraan; C Walsh; W Belizaire; M Tshibaka
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

Review 5.  Pathogenesis of antiphospholipid syndrome: understanding the antibodies.

Authors:  Pier Luigi Meroni; M Orietta Borghi; Elena Raschi; Francesco Tedesco
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

6.  Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.

Authors:  K E Moss; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-08       Impact factor: 7.580

7.  Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy.

Authors:  C Korkmaz; S Kabukcuoğlu; S Isiksoy; A U Yalçin
Journal:  Lupus       Date:  2003       Impact factor: 2.911

8.  Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.

Authors:  Laura Andreoli; Cecilia B Chighizola; Alessandra Banzato; Guillermo J Pons-Estel; Guilherme Ramire de Jesus; Doruk Erkan
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-11       Impact factor: 4.794

Review 9.  Diagnosis and therapy of antiphospholipid syndrome.

Authors:  Vittorio Pengo; Gentian Denas; Seena J Padayattil; Giacomo Zoppellaro; Elisa Bison; Alessandra Banzato; Ariela Hoxha; Amelia Ruffatti
Journal:  Pol Arch Med Wewn       Date:  2015-08-26

10.  Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

Authors:  G Banfi; T Bertani; V Boeri; T Faraggiana; G Mazzucco; G Monga; G Sacchi
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

View more
  3 in total

Review 1.  The role of the immune system in kidney disease.

Authors:  J Tecklenborg; D Clayton; S Siebert; S M Coley
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

2.  Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.

Authors:  Serena Yen Shan Tan; Richard Kent Sibley; Sharina Belani; Sumie Iwasaki; Leonid Yankulin; Tracy Jonelis; John Patrick Twistington Higgins; Neeraja Kambham; Megan Leigh Troxell
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

Review 3.  Renal Involvement in Antiphospholipid Syndrome.

Authors:  Alonso Turrent-Carriles; Juan Pablo Herrera-Félix; Mary-Carmen Amigo
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.